148 related articles for article (PubMed ID: 34754931)
1. A rare case of NXP-2 positive dermatomyositis.
Khan N; Kazmi ZH; Alkhateb R
Arch Clin Cases; 2020; 7(4):68-71. PubMed ID: 34754931
[TBL] [Abstract][Full Text] [Related]
2. [Two cases of anti-nuclear matrix protein 2 antibody-positive dermatomyositis sine dermatitis with severe diffuse subcutaneous edema and dysphagia].
Takahashi Y; Takamiya M; Ichimura Y; Okiyama N; Nishino I; Morimoto N
Rinsho Shinkeigaku; 2023 Nov; 63(11):737-742. PubMed ID: 37880118
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.
Albayda J; Pinal-Fernandez I; Huang W; Parks C; Paik J; Casciola-Rosen L; Danoff SK; Johnson C; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1771-1776. PubMed ID: 28085235
[TBL] [Abstract][Full Text] [Related]
4. [Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].
Miura E; Taneda T; Umeda Y; Umeda M; Oyake M; Matsushita T; Nishino I; Fujita N
Rinsho Shinkeigaku; 2024 Jun; 64(6):417-421. PubMed ID: 38797685
[TBL] [Abstract][Full Text] [Related]
5. NXP-2 Positive Dermatomyositis: A Unique Clinical Presentation.
Butt Z; Patel L; Das MK; Mecoli CA; Ramji A
Case Rep Rheumatol; 2017; 2017():4817275. PubMed ID: 28695037
[TBL] [Abstract][Full Text] [Related]
6. A Case of Dermatomyositis Coexisting with Both Anti-Mi-2 and Anti-NXP-2 Antibodies.
Ito M; Moriya C; Matsuyama K; Shu E; Hamaguchi Y; Seishima M
Case Rep Dermatol; 2020; 12(2):92-97. PubMed ID: 32508616
[TBL] [Abstract][Full Text] [Related]
7. [A case of dermatomyositis positive for anti-nuclear matrix protein 2 antibody without dermatologic symptoms].
Takeuchi E; Hirozawa D; Okiyama N; Inoue M; Nishino I; Sugai F
Rinsho Shinkeigaku; 2021 Apr; 61(4):258-261. PubMed ID: 33762494
[TBL] [Abstract][Full Text] [Related]
8. Dermatomyositis: A Cancer Red Flag.
Constante M; Barradas AR; Esteves AL; Pereira S; Silva L
Cureus; 2022 Dec; 14(12):e32502. PubMed ID: 36660526
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
[TBL] [Abstract][Full Text] [Related]
10. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
Liu Y; Zheng Y; Gang Q; Xie Z; Jin Y; Zhang X; Deng X; Hao H; Gao F; Zhang Z; Xiong H; Zhang W; Wang Z; Yuan Y
Eur J Neurol; 2020 Mar; 27(3):514-521. PubMed ID: 31571350
[TBL] [Abstract][Full Text] [Related]
11. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I
JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous and Systemic Findings Associated With Nuclear Matrix Protein 2 Antibodies in Adult Dermatomyositis Patients.
Rogers A; Chung L; Li S; Casciola-Rosen L; Fiorentino DF
Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1909-1914. PubMed ID: 28129490
[TBL] [Abstract][Full Text] [Related]
13. Dermatomyositis presenting with diffuse calcinosis.
Walsh M; Bettendorf B; Zahn C
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38103899
[TBL] [Abstract][Full Text] [Related]
14. Rehabilitation and Exercise in Dermatomyositis: A Case Report and Narrative Review of the Literature.
Calado D; Moeda F; Hatia M; Pinho S; Amaral-Silva M
Cureus; 2022 Dec; 14(12):e33034. PubMed ID: 36721601
[TBL] [Abstract][Full Text] [Related]
15. [Anti-nuclear matrix protein 2 antibody-positive dermatomyositis with the preferential involvement of neck extensors: a case report].
Fujii H; Kurashige T; Kubo S; Nakashima R; Hamaguchi Y; Kitamura T
Rinsho Shinkeigaku; 2021 Nov; 61(11):743-749. PubMed ID: 34657921
[TBL] [Abstract][Full Text] [Related]
16. A case of dermatomyositis in a patient with central core disease: unusual association with autoimmunity and genetic muscle disease.
Kim MJ; Kim MH; Park SH; Song YW
Pediatr Rheumatol Online J; 2021 Jun; 19(1):100. PubMed ID: 34193198
[TBL] [Abstract][Full Text] [Related]
17. Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay.
Wang L; Huang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Luo H; Zuo X; Li Y; Xiao X; Zhang H
Clin Rheumatol; 2018 Oct; 37(10):2731-2739. PubMed ID: 30039266
[TBL] [Abstract][Full Text] [Related]
18. Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis.
Toker M; Nazarian RS; Srivastava P; Amin B; Wu B
JAAD Case Rep; 2023 Mar; 33():77-80. PubMed ID: 36873052
[No Abstract] [Full Text] [Related]
19. Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature.
Cartron AM; Osler M; Chung C; Trinidad JC
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609448
[TBL] [Abstract][Full Text] [Related]
20. [A case of anti-nuclear matrix protein 2 antibody positive myopathy associated with lung cancer].
Ohta S; Unoda K; Nakajima H; Ikeda S; Hamaguchi Y; Kimura F
Rinsho Shinkeigaku; 2016 Aug; 56(8):573-6. PubMed ID: 27477574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
